Caring Deeply. Working Fearlessly. Changing Lives™.
Founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, we are one of the world’s first global biotechnology companies. Biogen leads innovative scientific research with the goal of defeating devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim of furthering medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition treatments from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of healthcare providers caring for people living with neurological diseases. We honour the important role of caregivers, families and friends.
Biogen is committed to working with advocacy and patient organisations as they serve the communities they represent.
Recognising the challenges facing healthcare systems today, we collaborate with regulatory authorities, healthcare providers and payers, so that those in need can access our medicines.
Professional, ethical and compliant, we hold ourselves accountable to deliver value.
Biogen contributes to the communities in which we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
BI-IRL-0329 Date of preparation: October 2018